DBCO-Val-Cit-PAB-MMAE is a drug-linker conjugate employed in the synthesis of ADC (antibody-drug conjugate) molecules. MMAE acts as a microtubule inhibitor, serving as the cytotoxic agent in ADCs. DBCO-Val-Cit-PAB functions as a linker with electrophilic groups.
Molekulargewicht:
1410.74
Reinheit:
99.25%
CAS Nummer:
[2768446-73-5]
Formel:
C77H107N11O14
Target-Kategorie:
Drug-Linker Conjugates for ADC
T212667
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten